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9 Abstract
10 Background Although a genetic component has been
11 identiﬁed as a risk factor for developing inﬂammatory
12 bowel disease, there is evidence that dietary factors also
13 play a role in the development of this disease.
14 Aims The aim of this study was to determine the effects
15 of feeding a red meat diet with and without resistant starch
16 (RS) to mice with dextran sulfate sodium (DSS)-induced
17 colitis.
18 Methods Colonic experimental colitis was induced in
19 Balb/c mice using DSS. The severity of colitis was eval-
20 uated based on a disease activity index (based on body-
21 weight loss, stool consistency, rectal bleeding, and overall
22 condition of the animal) and a histological score. Estima-
23 tions were made of numbers of a range of different bacteria
24 in the treatment pools of caecal digesta using quantitative
25 real-time PCR.
26 Results Consumption of a diet high in red meat increased
27 DSS-induced colitis as evidenced by higher disease activity
28and histopathological scores. Addition of RS to the red
29meat diet exerted a beneﬁcial effect in acute DSS-induced
30colitis. Subjective analysis of numbers of a range of bac-
31terial targets suggest changes in the gut microbiota abun-
32dance were induced by red meat and RS treatments and
33these changes could contribute to the reported outcomes.
34Conclusions A dietary intake of red meat aggravates
35DSS-induced colitis whereas co-consumption of resistant
36starch reduces the severity of colitis.
37
38Keywords Inﬂammation  Resistant starch  Red
39meat  Gut microbiota  Dextran sulfate sodium
40Abbreviations
41DSS Dextran sulfate sodium
42RS Resistant starch
43RM Red meat
44IBD Inﬂammatory bowel disease
45UC Ulcerative colitis
46CRC Colorectal cancer
47SCFA Short chain fatty acids
48AIN American Institute of Nutrition
49Hi-maize High amylose maize starch
50DAI Disease activity index
51SRB Sulfate-reducing bacteria
52aps Adenosine-5-phosphosulfate reductase gene
53
54
55Introduction
56Inﬂammatory bowel diseases (IBD), including Crohn’s dis-
57ease and ulcerative colitis (UC), result from complex inter-
58actions between environmental and genetic factors [1].
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59 Patients experience chronic relapsing symptoms that include
60 abdominal pain, diarrhoea, rectal bleeding and anaemia
61 resulting from intestinal inﬂammation, oedema and ulcera-
62 tion [2]. Although a genetic component has been identiﬁed as
63 a risk factor for developing IBD [3], there is evidence that
64 dietary factorsmay play a role in the development of IBD [4].
65 The incidence of IBD is high in western countries and is on
66 the increase in low-incidence areas such as southern Europe
67 and Asia, as well as developing countries that are now
68 adopting a westernised diet [5] [6].
69 A typical western diet is rich in red and processed meat
70 and poor in fruits and vegetables. Red meat has been
71 identiﬁed by the World Cancer Research Fund as a con-
72 vincing cause of colorectal cancer (CRC) [7] patients with
73 IBD also have a greater risk of developing CRC [8, 9]. In
74 contrast, a high intake of dietary ﬁbre, fruit, or vegetables
75 may be protective against the development of IBD [10] and
76 also CRC [7, 11]. Short-chain fatty acids (SCFAs) are
77 products that are derived from fermentation of unabsorbed
78 dietary ﬁbre and starch in the colon. The SCFA ‘‘butyrate’’
79 is important for colonic integrity as it is the principal
80 energy source for the colonic epithelium, inhibits growth of
81 cancer cells in vitro and forces a more normal differenti-
82 ated phenotype [12, 13]. A deﬁciency of SCFAs in the
83 intestinal lumen is often related with epithelium atrophy
84 and inﬂammation. In UC, an overall impaired butyrate
85 metabolism has been reported in several studies [14]. In a
86 rodent model of dextran sulfate sodium (DSS)-induced
87 colitis, oral administration of sodium butyrate has been
88 shown to improve mucosal lesions and attenuate the
89 inﬂammatory proﬁle of the intestinal mucosa and local
90 lymph nodes [15]. Also, Morita et al. [16] reported a pro-
91 tective effect of resistant starch (RS) in the form of high-
92 amylose cornstarch on trinitrobenzene sulfonic acid
93 (TNBS)-induced colitis in rats where enhancement of
94 mucosal protection was exerted possibly due to large bowel
95 SCFA production.
96 The DSS-induced colitis mouse model provides an
97 experimental model that displays many symptoms similar
98 to those seen in human UC, such as diarrhoea, bloody
99 faeces, body weight loss, mucosal ulceration, and short-
100 ening of the colorectum [17]. In the present study, we
101 determined the effects of feeding a diet high in red meat
102 with and without RS on DSS-induced colitis in Balb/c
103 mice.
104 Methods
105 Animals and Diets
106 Thirty-two male Balb/c mice were obtained from the
107 Animal Resource Centre, Perth, Western Australia, and
108housed in controlled conditions of 22 ± 2 C (SD),
10980 ± 10 % humidity, and 12-h light/dark cycle. Mice were
110acclimatized for a minimum of 1 week before com-
111mencement of the trial. Mice were then divided into four
112groups (n = 8) and fed one of four experimental diets
113(Table 1) for a period of 12 days. The experimental diets
114were modiﬁed forms of the AIN-76a standard for puriﬁed
115diets for rats and mice. The ﬁrst group ‘‘Control’’ con-
116sumed the modiﬁed AIN-76a diet. The second group ‘‘RS’’
117consumed high amylose maize starch (Hi-maize
 260;
118National Starch and Food innovation, Bridgewater, NJ,
119USA) at a level of 10/100 g diet. The third group ‘‘RM’’
120consumed cooked red meat at a level of 30/100 g diet. The
121fourth group ‘‘RM ? RS’’ consumed cooked red meat at a
122level of 30/100 g diet and high amylose maize starch at a
123level of 10/100 g diet.
124High amylose maize starch (Hi-maize 260), was used as
125the source of resistant starch and was supplied by the
126National Starch and Chemical Company. Hi-maize 260 has
127been shown to contain approximately 50 % resistant starch
128[18] and was added at a level of 10/100 g diet; therefore, a
129total of 5 % resistant starch was added to the diet. This
130proportion of starch consumed as RS in this RS-containing
131diet is feasible in the context of the human diet and is not
132likely to create any serious problem of side effects such as
133ﬂatulence and bloating [19]. Lean, minced rump steak was
134purchased, cooked at medium temperature on a gas hot-
135plate with continuous mixing to prevent the meat from
136burning, and oven-dried overnight before grinding to
137powder. Total nitrogen level of the cooked/dried red meat
Table 1 Composition of experimental diets
Ingredient Control RS RM RM ? RS
Casein 20 20 0 0
Red meat 0 0 30 30
Corn starch 15 5 15 5
Sucrose 37.93 37.93 31.13 31.13
High amylose maize starcha 0 10 0 10
Sunﬂower seed oil 16.8 16.8 16.8 16.8
Lardb 3.2 3.2 0 0
a-cellulose 2 2 2 2
L-cysteine 0.3 0.3 0.3 0.3
Choline 0.12 0.12 0.12 0.12
Mineral mixc 3.5 3.5 3.5 3.5
Vitamin mixc 1 1 1 1
Methionine 0.15 0.15 0.15 0.15
a High amylose maize starch (Hi-maize 260TM) used as the source of
resistant starch
b AIN-76 vitamin and mineral mixtures
c Lard was added to the Control and RS diets to balance each diet for
saturated fat and to give a total fat content of 20 %
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138 was determined by the Dumas method [20], and the total
139 protein content was calculated to be 73 %. Saturated fat
140 content of the red meat was 6 % when analysed by a
141 standard fat extraction method [21]. Moisture content of
142 the meat was found to be 10 % by weighing known
143 amounts of meat product and drying overnight to calculate
144 moisture lost from the sample. Final diet preparations were
145 placed into air-sealed containers and stored at 4 C, with
146 fresh food in the mouse cage bowls replaced daily.
147 The Flinders University of South Australia Animals
148 Welfare Committee approved all experimental procedures.
149 Induction of Colitis
150 Experimental colitis was induced by adding DSS (molec-
151 ular weight 36-50 kDa; MP Biomedicals) to the drinking
152 water at a level of 3 % for the ﬁrst 5 days of the study. All
153 mice received standard tap water from day 6 to day 12 of
154 the study.
155 Tissue Collection
156 Mice were anesthetised with a 10 % ketamine and 10 %
157 metotomodine solution at 75 mg/kg and decapitated 7 days
158 after DSS treatment. After dissection, the colon was
159 removed and placed into a 10 % buffered formalin solution
160 containing 3.6 % formaldehyde for 24 h and transferred to
161 70 % ethanol for histologic processing. Tissue was rehy-
162 drated through gradient alcohols and embedded in parafﬁn
163 wax for histological assessment.
164 Histopathological Anlaysis
165 Colon sections (5 lm) were stained with haematoxylin and
166 eosin and were independently and randomly coded so that
167 dietary groups were not known to the pathologist. Eight
168 randomly selected ﬁelds (magniﬁed 9100) were viewed
169 under a light microscope, and each section was graded and
170 averaged according to the method described by Cooper
171 et al. [22]. The severity of mucosal injury was graded as
172 follows: grade 0, normal—intact colonic crypt; grade 1,
173 slight—cystic dilatation of crypts; grade 2, mild—loss of
174 basal 1/3 of crypts; grade 3, moderate—loss of basal 2/3 of
175 crypts; grade 4, severe—loss of entire crypt with surface
176 epithelium remaining intact.
177 Disease Activity Index Assessment
178 Mice were scored daily using a Disease Activity Index
179 (DAI) based on weight loss, stool consistency, rectal
180 bleeding, and overall condition of the animal [23].
181 Each of these elements was scored on a 0–3 scale, with 0
182 representing no disease symptom and 3 representing severe
183disease symptom. Weight loss was scored as 0 representing
184no weight loss compared to the original weight, 1 repre-
185senting a weight loss of less than 5 %, two representing a
186weight loss of between 5 and 10 %, and three representing
187a weight loss of more than 10 % of the original weight. The
188grading of each variable was scored from 0 to 3. Data are
189the sum of scores for four independent variables.
190Bacterial Quantiﬁcation
191Caecal digesta collected from each mouse was combined
192into treatment group pools (insufﬁcient material was
193available for individual analysis). DNA was extracted
194from 0.25 g of each pool using the repeated bead beating
195plus column method of Yu and Morrison [24] and then
196used for estimation of numbers of target bacteria using
197quantitative real-time PCR (qRT-PCR). Each pool was
198analysed in quadruplicate. PCR reactions were carried out
199on a CFX Connect 96 real-time PCR detection system
200(Bio-Rad, Hercules, CA, USA) in a volume of 10 ll.
201Each reaction contained 1 ll DNA template, 5 ll SsoFast
202EvaGreen Supermix, 0.2 ll bovine serum albumin (0.5 ll
203DMSO used for SRB_APS reaction), primers (according
204to references below) and PCR-grade water. Bacterial
205assays were performed according to previous publications:
206Akkermansia muciniphila, Bifidobacterium spp. (84 C
207step before ﬂuorescence acquisition performed in this
208study), Clostridium coccoides group, Clostridium leptum
209group, Escherichia coli and Faecalibacterium prausni
210[25]; SRB_aps and total bacteria [26]; Entercoccus spp.
211and Parabacteroides distasonis [27]; Ruminococcus bro-
212mii (conditions like F. prausnitzii except 30 s annealing)
213primers used were he-10F and he-10R from [28]; Rumi-
214nococcus gnavus (conditions like F. prausnitzii except
21558 C annealing) [29]; Bacteroides–Prevotella (conditions
216like R. gnavus except 45 s annealing and 700 nM primer)
217[30]. A series of eight tenfold dilutions of a sample-
218derived standard for each amplicon were analysed with
219samples to estimate bacterial abundance and PCR efﬁ-
220ciency. It was not possible to examine differences
221between groups using statistical tests due to the lack of
222sample replication (due to the requirement for sample
223pooling).
224Statistical Analysis
225Qualitative DAI and semi quantitative histological severity
226scores were analysed using the non-parametric Kruskal–
227Wallis test with pairwise comparisons. For all analyses,
228P\ 0.05 was considered signiﬁcant. All data are expressed
229as the geometric mean ± standard error of the mean
230(SEM). Statistical comparisons were made using IBM
231SPSS for Windows software package V20.0 (Chicago, IL).
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232 Results
233 Clinical Symptoms and DAI
234 No mortality was observed in the control treatment,
235 whereas 1 mouse died from each of the RS and
236 RS ? RM groups and 3 mice died from the red meat
237 group. The DAI score was monitored daily over the
238 12 days (5 days DSS treatment followed by 7 days tap
239 water). DAI scores are shown in Fig. 1 and statistical
240 outcomes in Table 2. Signiﬁcant differences in DAI
241 scores were evident as early as day 2 with the RM
242 treatment group having signiﬁcantly higher scores than
243 all other treatment groups; this pattern was maintained to
244 day 5. There were no differences seen on days 6
245 between the different groups. On day 7, the RM group
246 was signiﬁcantly higher than the RS group. On day 8,
247 the RM group was signiﬁcantly higher than the Control
248 and RS groups. On days 9 and 10, the RM group dis-
249 played higher DAI compared to the RS group. No dif-
250 ferences were observed on days 11 and 12.
251 Histopathology Analysis
252 Histologically, the DSS model of colitis is characterized by
253 a disruption in crypt architecture, reduced crypt area and
254 increased inﬂammatory inﬁltrate. Figure 2 shows a repre-
255 sentative samples from each dietary group. Mice consum-
256 ing the red meat diet (RM) had signiﬁcantly higher
257 histological severity scores than the Control group and the
258 RS group (Fig. 3).
259Caecal Bacterial Analysis
260Estimations were made of numbers of a range of different
261bacteria in caecal digesta were quantiﬁed using qRT-PCR
262and are shown in Table 3. The caecal digesta from mice in
263each treatment group was pooled to provide sufﬁcient
264material for DNA extraction and analysis. Although sta-
265tistical analyses were not possible due to a lack of sample
266replication, a subjective comparison of means suggests a
267combination of red meat and RS treatment resulted in
268reduced numbers of C. coccoides, Enterococcus spp. and
269E. coli relative to other groups, and effects of red meat
270treatment on F. prausnitzii, P. distasonis, A. muciniphila,
271Bifidobacteria and the C. leptum group.
272Discussion
273The ﬁndings of the current investigation demonstrate that a
274diet high in red meat can increase the severity of DSS-
275induced colitis in mice whereas co-consumption of RS
276appears to reduce the severity of red meat-induced effects.
277Mice consuming the red meat diet alone demonstrated
278increased morbidity and mortality, heightened histological
279damage in the colon and enhanced DAI scores (from day 2
280to day 5). Addition of resistant starch appeared to protect
281against DSS-induced colitis, as it was observed that mice
282fed RS together with red meat had fewer mortalities, the
283enhancement of DAI by red meat through day 2 to day 5
284was ameliorated and the histopathology score was not
285signiﬁcantly different from controls.
286Epidemiological evidence suggests that diet plays a role
287in IBD [6]. Incidence rates of IBD have increased over the
288years in populations adopting a westernised diet [5, 6].
Time (days)
D
AI
0
0.5
1
1.5
2
2.5
3
1 2 3 4 5 6 7 8 9 10 11 12
Control
RS
RM
RM + RS
Fig. 1 Disease activity index (DAI) scores in mice monitored daily
over the 12 days (5 days DSS treatment followed by 7 days tap
water)
Table 2 Disease activity index (DAI) scores during the 12 days mice
were fed the different diets
Control RS RM RM ? RS
D1 0.03 ± 0.03 0.06 ± 0.04 0.03 ± 0.03 0.03 ± 0.03
D2 0.31 ± 0.04 a 0.28 ± 0.03 a 0.78 ± 0.06 b 0.34 ± 0.05 a
D3 0.34 ± 0.04 a 0.31 ± 0.06 a 0.87 ± 0.04 b 0.28 ± 0.03 a
D4 0.47 ± 0.10 a 0.62 ± 0.07 a 1.00 ± 0.05 b 0.50 ± 0.10 a
D5 0.53 ± 0.10 a 0.59 ± 0.07 a 1.10 ± 0.07 b 0.56 ± 0.08 a
D6 0.81 ± 0.11 0.88 ± 0.22 1.34 ± 0.25 1.06 ± 0.18
D7 0.97 ± 0.16 ab 0.94 ± 0.38 a 2.13 ± 0.33 b 1.34 ± 0.30 ab
D8 1.06 ± 0.17 a 1.15 ± 0.30 a 2.19 ± 0.25 b 1.40 ± 0.18 ab
D9 1.00 ± 0.21 ab 0.97 ± 0.23 a 2.21 ± 0.32 b 1.46 ± 0.11 ab
D10 0.90 ± 0.13 ab 0.68 ± 0.10 a 1.35 ± 0.31 b 1.10 ± 0.16 ab
D11 0.84 ± 0.16 0.54 ± 0.20 1.50 ± 0.61 1.10 ± 0.15
D12 0.90 ± 0.19 0.46 ± 0.18 1.42 ± 0.49 0.86 ± 0.20
Rows with different letters are signiﬁcantly different at P\ 0.05
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289 Animal protein, particularly red meat, [31–33], has been
290 singled out as a possible risk factor as contributing to the
291 development of IBD. Plausible explanations of why
292 increased red meat intake may contribute to IBD may
293 include increased delivery of amino acids and heme to the
294 colon where they undergo fermentation and metabolism by
295 the colonic microbiota [34], which results in the generation
296 of potentially toxic substances such as ammonia, amines,
297 N-nitroso compounds, phenols, cresols and hydrogen sul-
298 ﬁde [35, 36]. Increased dietary heme from haemoglobin in
299 red meat can form reactive oxygen species, [37] Sesink
300 et al. [38] showed that dietary heme increases luminal
301 cytotoxicity which causes damage to the colonic
302epithelium. Previous animal studies by us have also shown
303that red meat consumption results in a thinning of the
304colonic mucus layer and increases damage to the colono-
305cytes in the form of DNA strand breaks [39] or pro-
306mutagenic adducts [40].
307Mice consuming RS along with the red meat diet had
308reduced clinical signs of colitis when compared to mice fed
309only the red meat diet. Furthermore, the RM ? RS mice
310did not differ from the control mice for either histopa-
311thological severity or daily DAI scores. There are a number
312of potential reasons why RS may improve or prevent
313colonic inﬂammation. RS is the portion of starch that
314resists digestion in the small intestine and enters the large
315bowel, and so contributes to total dietary ﬁbre intake [41,
31642]. In the large bowel, RS is fermented by the microbiota,
317resulting in the production of butyrate which improves
318colonic physiology [42, 43] as well as providing a major
319source of energy for the growth of microorganisms [44].
320Although SCFA levels were not measured in the current
321study, we have previously reported signiﬁcant increases in
322total SCFA and butyrate in mice and rats consuming sim-
323ilar dietary RS levels to those used in the present study [40,
32445]. Additional studies have also shown that adding RS to a
325diet high in red meat profoundly alters protein and carbo-
326hydrate fermentation in a manner that can be interpreted as
327constituting a more favourable luminal environment [40,
32846–48].
329The gut bacterial population proﬁles of individuals with
330IBD are altered compared to healthy individuals, including
331a reduced overall diversity of microbes [28, 29, 49]. In this
Fig. 2 Histological analysis of
DSS treated mice. a Colon
section from control fed mouse
showing normal architecture
(HE, 9100); b colon section
from RS fed mouse showing
normal architecture (HE,
9100); c colon section from red
meat (RM) fed mouse showing
crypt inﬂammation and
moderate damage (HE, 9100);
d colon section from RM ? RS
fed mouse showing
inﬂammation and minor damage
(HE, 9100), the tissue damage
was less severe than in C
damage (HE, 9100)
0
0.5
1
1.5
2
2.5
3
3.5
4
Control RS RM RM + RS
H
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to
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b
Fig. 3 Histopathology severity scores. Bars with different superscript
letters are signiﬁcantly different at P\ 0.05
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332 study, we have examined effects of treatment on gut pop-
333 ulations of a range of bacteria that are implicated in IBD or
334 bowel health broadly. Our targets included F. prausnitzii,
335 R. bromii, P. distasonis, the C. coccoides group and the C.
336 leptum group that are associated with fermentation of
337 complex carbohydrates and production of SCFA, and
338 generally thought to provide beneﬁt. Numbers of the latter
339 two groups are also low in IBD [49], and F. prausnitzii is
340 of additional interest due to its anti-inﬂammatory effects
341 and lower numbers in the gut of individuals with colitis
342 [50, 51]. Populations of A. muciniphila and R. gnavus,
343 which contribute to mucus turnover and are altered in IBD
344 [29], were also examined. Other targets were accepted
345 markers of bowel health (Bifidobacterium spp. and Lacto-
346 bacillus spp.), bacteria often associated with poor health
347 outcomes (E. coli, Enterococcus spp.), and some groups
348 that may play a role in health (Bacteroides–Prevotella,
349 sulfate-reducing bacteria). Although the contribution of
350 bacteria to the increased colonic damage that can occur in
351 response to diets high in red meat is poorly deﬁned, it is
352 likely that they have a role as many of the products that are
353 produced in the gut following bacterial fermentation of
354 proteins are toxic. Similarly, bacteria are implicated in the
355 protection against dietary protein-induced increases in
356 colonic DNA damage that occurs in response to con-
357 sumption of RS, primarily because production of SCFA via
358 bacterial action, especially of butyrate, correlates strongly
359 with protection [52]. In our study, we were unable to carry
360 out deﬁnitive analyses of the gut microbiota due to con-
361 straints related to the amount of digesta available. How-
362 ever, our subjective analysis of numbers of a range of
363 bacterial targets suggests there were changes in the abun-
364 dance of some bacteria in response to red meat and RS
365 treatments, and these changes could contribute to the
366reported outcomes. Some of the changes suggested by our
367limited microbial data, such as drops in numbers of A.
368muciniphila and bacteria belonging to the C. coccoides and
369C. leptum groups in response to the red meat diet in DSS-
370treated mice, are also observed in the large bowel mucosa
371of humans with Crohn’s disease [29, 49], suggesting sim-
372ilar mechanisms may be at play in our DSS animal model
373of colitis.
374In conclusion, dietary red meat worsens the histopa-
375thology, inﬂammatory indicators and clinical signs in DSS-
376induced colitis, whereas resistant starch added to a high red
377meat diet reduces the severity of colitis. Changes in the gut
378microbiota by consumption of red meat and resistant starch
379may play a role in the modulation of the severity of the
380DSS-induced colitis. Further studies are required to eluci-
381date the mechanisms involved in the worsening of colitis
382by red meat and beneﬁcial effects of resistant starch in a
383suitable model.
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